The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

As American Merck (MSD) accelerates its plan to launch the cancer drug Keytruda in a subcutaneous injection (SC) formulation instead of an intravenous injection (IV), a patent dispute has erupted over ...

Tens of thousands of patients could benefit from a one-minute jab being rolled out on the NHS for more than a dozen cancers. The immunotherapy injection works by telling the body’s immune system to ...